Add BrightSurf on Google Email

New study may offer hope to women suffering menopausal hot flashes, night sweats

A new study from the University of Victoria found that higher insulin levels at age 47 predicted younger onsets of hot flashes and night sweats. Insulin may be a stronger predictor of hot flashes when taking other metabolic variables into account, while body mass index (BMI) appeared more closely associated with estrogen level changes.

SourceUniversity of Victoria·JournalThe Journal of Clinical Endocrinology & Metabolism·TypeObservational study·DateJan 26, 2026

Major breakthrough against diabetes thanks to a microbial molecule that disarms inflammation

Researchers have uncovered a microbial metabolite called trimethylamine (TMA) that can block a key immune pathway and improve blood sugar control. TMA, produced by gut bacteria from dietary choline, targets IRAK4, a protein that triggers inflammation and insulin resistance in diabetic individuals.

SourceUniversité catholique de Louvain·JournalNature Metabolism·TypeObservational study·DateDec 8, 2025

Landmark multi-center trial: Transcendental Meditation cuts diabetes risk and supports weight loss in Black women

A landmark clinical trial found that Transcendental Meditation significantly reduced diabetes risk factors and supported weight loss in older Black women at high risk for heart disease. Meditation improved blood sugar control, insulin resistance, cholesterol, and weight.

SourceMaharishi International University·JournalJournal of Women s Health·TypeRandomized controlled/clinical trial·DateAug 28, 2025

The link between immune aging and type 2 diabetes

This review synthesizes evidence highlighting immune aging as a critical accelerator of type 2 diabetes pathogenesis. Chronic low-grade inflammation, organelle stress pathways, and the ominous octet framework contribute to metabolic-inflammatory vortex, disrupting β-cell function and insulin signaling.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateAug 6, 2025

New study validates insulin nasal spray to deliver Alzheimer’s drug directly to the brain

A groundbreaking brain imaging study confirms intranasal insulin safely reaches key memory regions in older adults with Alzheimer's. The research reveals differences in uptake among individuals with early cognitive decline, paving the way for personalized treatment approaches.

SourceAtrium Health Wake Forest Baptist·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·DateJul 23, 2025

Newly discovered ‘molecular fingerprints’ could transform diabetes treatment and diagnosis

Researchers have uncovered unique molecular fingerprints for insulin sensitivity, challenging traditional binary classification of people with type 2 diabetes. These signatures can help identify individuals at risk earlier than current methods, paving the way for personalized treatments and precision medicine.

High blood sugar in adolescence tripled the risk of premature heart damage affecting females worse than males

A recent study published in Diabetes Care found that persistently high blood sugar and insulin resistance significantly increased the risk of worsening functional and structural heart damage during adolescence to young adulthood. The study showed a five-fold increase in prediabetes prevalence among adolescents, with females being dispr...

SourceUniversity of Eastern Finland·JournalDiabetes Care·DateApr 28, 2025

The pathophysiological relationship and treatment progress of obstructive sleep apnea syndrome, obesity, and metabolic syndrome

The review explores the pathophysiological mechanisms linking obstructive sleep apnea syndrome and metabolic syndrome, highlighting recent advancements in therapeutic strategies. Treatment approaches aim to break the harmful cycle between OSA and MetS, which affects approximately 14% of the global population.

SourceXia & He Publishing Inc.·JournalExploratory Research and Hypothesis in Medicine·DateMar 19, 2025

Mount Sinai researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes

Researchers have discovered a novel approach to protecting insulin-producing beta cells from glucolipotoxicity, a condition linked to type 2 diabetes progression. The findings could lead to promising treatments targeting beta cell dysfunction, potentially slowing or preventing disease progression.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalNature Communications·TypeExperimental study·DateMar 4, 2025

New molecular mechanisms linked to insulin resistance

A study published in Cell Communication and Signaling describes new molecular mechanisms underlying insulin resistance in skeletal muscle. The research reveals that PPARβ/δ regulates InsRβ protein levels by reducing lysosomal activity and EphB4 levels, offering potential drug targets for type 2 diabetes.

SourceUniversity of Barcelona·JournalCell Communication and Signaling·TypeExperimental study·DateFeb 19, 2025

Brain network disorders review uncovers the link between metabolic disorders and Alzheimer's disease

Researchers explore the connection between Alzheimer's and metabolic syndrome, finding links between insulin regulation, high blood pressure, and obesity. The study suggests that maintaining healthy blood fat levels may be crucial for brain health, paving way for potential therapeutic developments.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateFeb 18, 2025

New study finds lower cardiovascular risk in Type 1 diabetes compared to Type 2 diabetes

A new study published in JSCAI reveals a lower risk of cardiovascular events for people with Type 1 diabetes, compared to those with Type 2 diabetes. The research highlights the importance of distinguishing between the two types of diabetes and developing targeted treatment strategies.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateFeb 12, 2025

A weekly injection could replace painful daily treatment for rare fat disorder

Researchers at Rutgers University have discovered that a weekly injection of diabetes medication can replace painful daily hormone shots for people with a rare genetic form of lipodystrophy. The study found that the drug tirzepatide improved insulin resistance and normalized blood glucose levels in patients, reducing the burden and pai...

SourceRutgers University·JournalNew England Journal of Medicine·TypeExperimental study·DateJan 29, 2025

Many Greenlanders face 10 times higher risk of diabetes – exercise may be their only solution

A study published in Nature Metabolism found that four percent of Greenland's Inuit population has a gene variant that increases their risk of type 2 diabetes by tenfold. Exercise has been shown to increase insulin sensitivity in these individuals, suggesting it may be an effective way to reduce their risk of developing the disease.

SourceUniversity of Copenhagen - Faculty of Science·JournalNature Metabolism·DateJan 19, 2025

World’s most common heart valve disease linked to insulin resistance in large national study

Researchers found a novel link between aortic stenosis and insulin resistance, with certain biomarkers increasing the risk of the disease. The study's findings suggest that managing metabolic health could be a new approach to reduce the risk of AS and improve cardiovascular health in aging populations.

SourceTaylor & Francis Group·JournalAnnals of Medicine·TypeData/statistical analysis·DateNov 27, 2024

Study advances understanding of metformin effects on fetus

Metformin, a widely prescribed diabetes drug, may increase risks of obesity and diabetes in newborns when given to pregnant women. The study found that the drug accumulated in the fetal kidneys, liver, and other organs, leading to growth restriction, which has been linked to an elevated risk of obesity and insulin resistance in childhood.

SourceUniversity of Oklahoma·JournalAmerican Journal of Obstetrics and Gynecology·TypeExperimental study·DateNov 12, 2024

Babies born to women consuming a high fat, sugary diet at greater risk of cardiovascular disease and diabetes in later life

Research found that babies born to pregnant women consuming high-fat, high-energy diets are more likely to develop heart problems and diabetes as adults due to fetal damage. Consuming a high-fat diet during pregnancy also increases the likelihood of insulin resistance in adulthood.

SourceUniversity of South Australia·JournalThe Journal of Physiology·TypeExperimental study·DateSep 12, 2024

Does low lipoprotein(a) increase the risk of diabetes? New research suggests it does not

Researchers used genetic method Mendelian randomization to show high levels of fasting insulin cause reduction in Lp(a), rather than the other way around. Low Lp(a) is unlikely to be a risk factor for type 2 diabetes, independent of pre-existing hyperinsulinaemia and insulin resistance.

SourcePolskie Towarzystwo Lipidologiczne (Polish Lipid Association)·JournalCardiovascular Diabetology·TypeData/statistical analysis·DateAug 29, 2024

Inflammation during childhood linked to onset of mental health issues in early adulthood – study reveals

A recent study published in JAMA Psychiatry found that children with persistently raised inflammation are at a higher risk of experiencing serious mental health disorders, including psychosis and depression, in early adulthood. The research also discovered that those who experienced inflammation at a young age were more likely to devel...

SourceUniversity of Birmingham·JournalJAMA Psychiatry·TypeObservational study·DateAug 21, 2024

Obesity-induced inflammation increases the secretion of extracellular vesicles from adipose tissue

Research from the University of Eastern Finland found that obesity-induced inflammation increases the secretion of extracellular vesicles from human adipocytes, which may contribute to the detrimental health effects of obesity. Visceral adipose tissue secretes more extracellular vesicles than subcutaneous adipose tissue.

SourceUniversity of Eastern Finland·JournalJournal of Translational Medicine·DateAug 19, 2024